期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
Does St.John's Wort cause regression in gastrointestinal system adenocarcinomas?
1
作者 Serap Karaarslan Suna Cokmert Atilla Cokmez 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2015年第11期369-374,共6页
St.John's Wort(SJW) is an old herb which has long been consumed widely for its anti-inflammatory,antiviral,and anti-depressive properties.Here we present a detailed clinical evaluation of three cases(two colon and... St.John's Wort(SJW) is an old herb which has long been consumed widely for its anti-inflammatory,antiviral,and anti-depressive properties.Here we present a detailed clinical evaluation of three cases(two colon and one duodenal adenocarcinoma) with remarkable and intensive lymphoplasmocytic host reaction,at the basal part of tumor,intensive fibrosis,giant cells,plasma cell increase in lymph nodes and few giant cells in germinal centers in resection specimens.The observation of similar host reaction in those tumors having otherwise usual appearance was interesting.None of the cases received neoadjuvant chemoradiotherapy or additional treatment before surgery but only SJW.These cases are presented to increase the awareness about such cases.Further research is needed to reveal the possible effect of SJW,which has long been consumed for different treatment purposes,on human tumors. 展开更多
关键词 st.john’s wort ADENOCARCINOMA Giant cell
下载PDF
Effect of St. John's wort extract on depressive disorder in elderly patients with unstable angina
2
作者 Jian Liu Zhao-wci Mcng +2 位作者 Li-yu Li Li-sha Fcng Hui Yang 《World Journal of Emergency Medicine》 SCIE CAS 2010年第1期41-44,共4页
The elderly patients with coronary heart disease (CHD) are often accompanied with depression. This study aimed to assess the effect of St. John's wort extract (SWE) on depressive disorder in elderly patients with... The elderly patients with coronary heart disease (CHD) are often accompanied with depression. This study aimed to assess the effect of St. John's wort extract (SWE) on depressive disorder in elderly patients with unstable angina pectoris. Altogether 170 patients who met the set criteria were enrolled in this prospective study. They were randomly divided into SWE group (44 patients), Deanxit group (44), psychotherapy group (42), and control group (40). The effectiveness of SWE was evaluated by reduced percentage of Hamilton depression (HAMD) scale and reduced frequency of angina pectoris attack, which were measured before and at 12 weeks after the treatment with SWE. The reduced percentages of HAMD scale were 79.5%, 56.8% and 57.1% in the SWE, Deanxit and psychotherapy groups, respectively. Compared with the control, the three groups had significant differences in the percentages (P〈0.001). The improvement after the treatment was more significant in the SWE group than in the Deanxit or psychotherapy group (P〈0,05). The improvement of angina pectoris evaluated by the Canadian Cardiac Society Classification was significantly better in the treatment groups (88.7%, 65.9%, 57.1%) than in the control group, and it was marked in the SWE group (P〈0.001). Angina pectoris attack, its frequencies, durations and electrocardiographic changes were significantly improved in the treatment groups than in the control group (F=6.05, 4.58, 5.12, P〈0.01). They are markedly improved in the SWE group (P〈0.05). SWE can improve depressive symptoms more significantly in elderly patients with unstable angina pectoris than Deanxit or psychotherapy, proving that SWE contributes to better treatment of angina attack as well. 展开更多
关键词 st. johns wort extract DEPREssION Elderly patients Coronary heart disease Unstable angina pectoris PsYCHOTHERAPY
下载PDF
Anxiety-Inducing Dietary Supplements: A Review of Herbs and Other Supplements with Anxiogenic Properties
3
作者 Caitlin E. McCarthy Danielle M. Candelario Mei T. Liu 《Pharmacology & Pharmacy》 2014年第10期966-981,共16页
Anxiety disorders comprise the most common group of mental disorders to affect the general population in the United States. These disorders are heterogeneous in nature, highly comorbid with one another, and pose a deg... Anxiety disorders comprise the most common group of mental disorders to affect the general population in the United States. These disorders are heterogeneous in nature, highly comorbid with one another, and pose a degree of difficulty regarding diagnosis and management. The exact etiology and pathophysiology of anxiety remains to be elucidated;however, it is likely that it is multifactorial, and all potential causes of anxiety must be investigated, including substance-induced anxiety. Among substances that may induce anxiety are dietary supplements. As utilization of these products appears to be high in the US population, it is important to identify which of available supplements may cause anxiety. Objective: To review the scientific literature to identify dietary supplements associated with induction of anxiety and related symptoms. Methods: A search of Natural Medicines Comprehensive Database, MedlinePlus Herbs and Supplements, and Natural Standard was performed to identify dietary supplements with anxiogenic properties. Dietary supplements were included based on product availability, utilization trends, and if there was sufficient evidence that the substance could elicit anxiety via direct pharmacologic effects. Agents were excluded from the review if anxiety was solely due to withdrawal from the substance or only occurred in the setting of intoxication. A search of MEDLINE and PUBMED was performed to identify relevant peer reviewed publications concerning induction of anxiety and/or its associated symptoms by those dietary supplements chosen for review. Conclusions: Dietary supplements can contribute to and cause anxiety and its related symptoms via overstimulation of the Central Nervous System. Healthcare professionals should screen all patients presenting with symptoms consistent with anxiety for recent or current use of all products capable of inducing anxiety, including dietary supplements. 展开更多
关键词 ANXIETY Adverse Effects Dietary sUPPLEMENTs st. john’s wort CAFFEINE
下载PDF
路优泰联合心理干预治疗对脑卒中后抑郁疗效观察 被引量:2
4
作者 周茵 刘英 宋雷凤 《黑龙江医药》 CAS 2010年第3期350-352,共3页
目的:观察抗抑郁剂圣·约翰草提取物(路优泰)联合心理干预治疗对脑卒中后抑郁及神经功能康复的影响。方法:将66例脑卒中后抑郁患者,随机分为联合治疗组和对照组各33例。对照组按病情分别给予抗凝、溶栓、脱水、利尿、降压、降血糖... 目的:观察抗抑郁剂圣·约翰草提取物(路优泰)联合心理干预治疗对脑卒中后抑郁及神经功能康复的影响。方法:将66例脑卒中后抑郁患者,随机分为联合治疗组和对照组各33例。对照组按病情分别给予抗凝、溶栓、脱水、利尿、降压、降血糖及营养脑神经等常规治疗;联合治疗组则在此基础上加服圣·约翰草提取物,300mg/次,一日三次,疗程为8周;两组均进行综合及个体心理治疗,未采用其他抗抑郁药物。在治疗前和治疗后4周、8周分别进行改良爱丁堡-斯堪的那维亚卒中量表(MESSS)和汉密尔顿抑郁量表(HAMD)评分。结果:与对照组相比,联合治疗组HAMD评分和MESSS评分的减分率均较高,疗效明显优于对照组。结论:圣·约翰草提取物联合心理干预治疗可明显改善脑卒中后抑郁症状,促进神经功能的康复,副作用小,安全有效。 展开更多
关键词 脑卒中 抑郁 神经功能 康复 圣·约翰草提取物
下载PDF
连翘中连翘苷提取方法的比较
5
作者 房辉 胡倩莲 +2 位作者 李竹君 李心怡 杨阳 《广东化工》 CAS 2021年第13期61-62,共2页
目的:比较不同前处理方法对连翘中连翘苷的萃取效率的影响。并建立检测连翘苷的方法,利用建立的方法对双黄连口服液中连翘苷进行鉴别和含量测定。方法:采用高效液相色谱法,以ODS C18(150 mm×4.6 mm×5μm)不锈钢柱为色谱柱,乙... 目的:比较不同前处理方法对连翘中连翘苷的萃取效率的影响。并建立检测连翘苷的方法,利用建立的方法对双黄连口服液中连翘苷进行鉴别和含量测定。方法:采用高效液相色谱法,以ODS C18(150 mm×4.6 mm×5μm)不锈钢柱为色谱柱,乙腈-水(25∶75)为流动相,检测波长为278 nm,流速1.0 mL/min,以外标法按峰面积计算连翘苷的含量为参考指标,来探讨不同前处理方法的提取效率。然后采用薄层色谱法来鉴别双黄连口服液中连翘苷。结果:正相分配色谱法萃取连翘中连翘苷的分离效率高于反相分配色谱法。双黄连口服液中含有连翘苷。结论:正相分配色谱法比反相分配色谱法分离效率更好。薄层色谱法直接就可鉴别双黄连口服液中含有连翘苷,操作简便。 展开更多
关键词 双黄连口服液 高效液相色谱法 连翘苷 薄层色谱法 前处理
下载PDF
基于正交试验优选脉安颗粒天然澄清剂精制工艺 被引量:2
6
作者 尚海宾 王杰 张文标 《化工与医药工程》 2020年第5期19-23,共5页
为减少中药有效成分在精制醇沉法制备过程中的损失,充分利用其药物疗效,选用ZTC1+1Ⅱ型天然澄清剂对脉安颗粒提取液进行精制工艺研究,为中药颗粒剂、口服液、糖浆剂、合剂等相关中药制剂的精制工艺研发,提供必要的参考依据。基于正交试... 为减少中药有效成分在精制醇沉法制备过程中的损失,充分利用其药物疗效,选用ZTC1+1Ⅱ型天然澄清剂对脉安颗粒提取液进行精制工艺研究,为中药颗粒剂、口服液、糖浆剂、合剂等相关中药制剂的精制工艺研发,提供必要的参考依据。基于正交试验L9(3)4优选脉安颗粒天然澄清剂精制工艺,以提取液外观、浸膏枸橼酸含量、金丝桃苷含量为考察指标。优选的脉安颗粒天然澄清剂精制工艺为:提取液浓缩后的料液比(g∶g)为1∶3、提取液加入澄清剂的温度为70℃、澄清剂加入量为15%,即B组分10%、A组分5%。优选的脉安颗粒精制工艺重现性好,操作简便,为ZTC1+1天然澄清剂在中药颗粒剂、口服液、糖浆剂、合剂等相关中药制剂的精制工艺步骤的应用,提供了参考数据。 展开更多
关键词 脉安颗粒 正交试验 ZTC1%PLUs%1Ⅱ型天然澄清剂 精制工艺 枸橼酸 金丝桃苷
下载PDF
圣·约翰草提取物对老年不稳定型心绞痛患者伴发抑郁症的疗效 被引量:4
7
作者 刘健 孟召伟 +2 位作者 李立宇 冯丽莎 杨慧 《中华急诊医学杂志》 CAS CSCD 北大核心 2010年第4期397-400,共4页
目的探讨抗抑郁植物药圣·约翰草提取物辅助治疗伴发抑郁症的老年不稳定型心绞痛患者的临床疗效。方法前瞻性研究天津医科大学第二医院2006年10月至2008年9月住院的老年不稳定型心绞痛并发抑郁症患者170例,年龄65~75岁。排除双相... 目的探讨抗抑郁植物药圣·约翰草提取物辅助治疗伴发抑郁症的老年不稳定型心绞痛患者的临床疗效。方法前瞻性研究天津医科大学第二医院2006年10月至2008年9月住院的老年不稳定型心绞痛并发抑郁症患者170例,年龄65~75岁。排除双相障碍和重性精神病患者、严重自杀倾向者,入选前3个月未应用抗精神药物。将入选170例患者随机分为4组:圣·约翰草提取物组(n=44)、黛力新组(n=44)、心理治疗组(n=42)和对照组(n=40),4组患者基线资料差异无统计学意义,均治疗12周。以汉密尔顿抑郁量表(HAMD)减分率评定疗效,以临床心绞痛发作及心电图改变判定临床疗效。统计学处理采用SPSS11.5统计软件包分析,计量资料采用(x±s)表示,治疗前、后两组间比较采用配对t检验,计数资料多组间比较采用X^2检验,计量资料多组间比较采用F检验,P〈0.05为差异具有统计学意义。结果(1)治疗组HAMD减分率分别为79.5%,56.8%,57.1%,与对照组比较,差异具有统计学意义(X^2=29.9,P〈0.001),圣·约翰草组疗效优于黛力新组及心理组(P〈0.05);(2)治疗组加拿大心血管学会(CCS)心绞痛分级比较,显效率分别为88.7%,65.9%,57.1%,与对照组比较,差异具有统计学意义(X^2=15.4,P〈0.001),圣·约翰草组优于黛力新组及心理组(P〈0.05)。(3)治疗组心绞痛发作次数、发作持续时间、发作时心电图缺血改善明显优于对照组,差异具有统计学意义(F分别为值6.05,4.58,5.12,P〈0.01),圣·约翰草组优于黛力新组及心理组(P〈0.05)。结论圣·约翰草提取物能显著改善老年不稳定型心绞痛患者伴发的抑郁症,且有利于临床心绞痛发作的控制。 展开更多
关键词 圣·约翰草提取物 抑郁症 老年 冠心病 不稳定型心绞痛 心理治疗
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部